PaxeraHealth develops medical imaging solutions that help healthcare organizations to automate their imaging workflow, elevate patient care, and cut imaging department picture archiving and communication system costs. It provides an enterprise imaging platform with technology at its core and includes an artificial intelligence-integrated image-sharing platform that manages universal viewers and advanced specialized tools for different imaging departments. The company was founded in 2009 and is based in Newton Center, Massachuetts.
PaxeraHealth's Product Videos
Compete with PaxeraHealth?
Ensure that your company and products are accurately represented on our platform.
PaxeraHealth's Products & Differentiators
PaxeraUltima 8th Gen
An AI-based Enterprise Imaging Platform that detects 20 acute abnormalities (Chest X-ray, Mammography, and Brain CT) as they enter the worklist, helping radiologists prioritize life-threatening cases, improve efficiency, and expedite patient care. With thousands of built-in commands, the system's chatbot "EraBot" is able to interact seamlessly with users via speech and text, gives them access to radiology resources during reading or dictation, as well as pulls relevant patient data from the EMR directly on the viewing screen alongside images.
Expert Collections containing PaxeraHealth
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
PaxeraHealth is included in 4 Expert Collections, including Conference Exhibitors.
Health Monitoring & Diagnostics
Companies developing technology for computer-aided diagnostic imaging. Companies tagged as #ComputerAidedDxImaging
Clinical Encounter Tech
Latest PaxeraHealth News
Dec 22, 2022
Noteworthy market developments listed in the order announcements were posted. Imaging AI platform developer PaxeraHealth (Boston) has closed a series A funding round of undisclosed amount. The round was led by Sopris Capital, a venture capital firm based in Colorado that says it’s focused on technology-enabled healthcare solutions ( Dec. 16 ). Paxera founder and CEO Mohamed Shoura, PhD: “Our goal is not to build yet another AI algorithm but to democratize AI in medical imaging and make it accessible, affordable and faster to deploy. [Our] industry-first ‘algorithm as a service’ platform is designed to enable healthcare facilities to create AI algorithms with no coding, using their own imaging datasets.” Butterfly Network (Burlington, Mass.) has completed the first phase of its POCUS equipment donation and user training program in Kenya. The phase saw the company deliver 500 of its handheld IQ+ ultrasound devices and train 1,000 midlevel maternal-fetal practitioners to use them ( Dec. 19 ). Sachita Shah, MD, Butterfly Network’s senior director of global health: “Maternal mortality from pregnancy and childbirth-related complications still occur at exceedingly high rates in Sub-Saharan Africa due to limited access to standard resources for maternal fetal care. Witnessing such interest and fast adoption of our advanced, digital device in these clinics has been inspirational.” Israel-based TechsoMed has established a subsidiary R&D operation in Germany to further develop TechsoMed’s software for image-guided tumor ablation ( Dec. 19 ). The company is partnering in the work with the applied research organization Fraunhofer Institute for Digital Medicine Mevis. TechsoMed CEO Yossi Abu: “This new strategic collaboration plays an important role in TechsoMed’s roadmap to transform ablation therapy into a precise, feedback-dependent treatment and create a true impact on patient care worldwide.” Scottish ultrasound sensor maker Novosound (Glasgow) is partnering with medical device developer PAVmed (New York City) to advance intravascular imaging ( Dec. 21 ). Novosound CEO and co-founder Dave Hughes: “PAVmed has a strong track record in delivering commercial stage medical technology across medical devices, diagnostics. and digital health.” PAVmed chairman and CEO Lishan Aklog, MD: “Novosound’s proprietary ultrasound technology has the potential to be a once-in-a-generation breakthrough in medical imaging. We are excited to partner with Novosound with the goal of revolutionizing the global intravascular imaging market.” iThera Medical of Munich, Germany, has closed a financing round of 13 million euros (around $13.8 million) to fund translation of their flagship imaging technology from research settings into routine clinical use ( Dec. 21 ). The technology, multispectral optoacoustic tomography (MSOT), converts light energy into sound waves so clinicians can visualize optical contrast at high resolution in deep tissue. Company CEO and co-founder Christian Wiest: “The proceeds from this funding round will be used to develop a next-generation MSOT device optimized for routine clinical use, to secure regulatory approval for deployment in Europe (CE mark) and the United States (FDA clearance) and to significantly expand clinical evidence in priority clinical indications.”
PaxeraHealth Frequently Asked Questions (FAQ)
When was PaxeraHealth founded?
PaxeraHealth was founded in 2009.
Where is PaxeraHealth's headquarters?
PaxeraHealth's headquarters is located at 85 Wells Avenue, Newton Center.
What is PaxeraHealth's latest funding round?
PaxeraHealth's latest funding round is Series A.
How much did PaxeraHealth raise?
PaxeraHealth raised a total of $5.5M.
Who are the investors of PaxeraHealth?
Investors of PaxeraHealth include Sopris Capital Associates.
Who are PaxeraHealth's competitors?
Competitors of PaxeraHealth include Lunit and 6 more.
What products does PaxeraHealth offer?
PaxeraHealth's products include PaxeraUltima 8th Gen and 4 more.
Compare PaxeraHealth to Competitors
Aidoc finds and flags critical findings in medical images. By automatically prioritizing urgent, life-threatening conditions like intracranial hemorrhage and pulmonary embolism, Aidoc saves lives, improves patient care and cuts waiting time for the must urgent patients down to only a few minutes. The always-on AI integrates into a radiologist's workflow, reprioritizing cases without forcing radiologists to change the way they work. Aidoc was founded in 2016 and is based in Tel Aviv, Israel.
Quibim, a company with its headquarters in Valencia, Spain, provides a whole-body medical imaging analysis. Quibim products are used worldwide by a huge diversity of research and care teams. Partners use Quibim Precision, a CE-marked whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers.
Enlitic develops a diagnosis system that uses deep learning to analyze medical data in order to enable quick and more accurate detection of diseases that can be identified through medical images such as X-rays and CT scans.
Viz.ai aims to use artificial intelligence and deep learning to automatically identify suspected LVOs (large vessel occlusion) on CTA imaging with the aim of alerting a patient's physician within minutes. The company was founded in 2016 and is based in San Francisco, California.
Caption Health has developed an AI platform that enables heart ultrasound access for early disease detection. Its Caption Care services offers health providers, payers, and value-based care organizations convenient and cost-effective echocardiograms for their members, leveraging its Caption Atlas technology platform. Caption Health was founded in 2013 and is based in San Mateo, California.
Cancer Center provides improved diagnosis of cancer by machine and deep learning.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.